Clearance Summary
TINA-QUANT CRP received FDA 510(k) clearance under submission number K930621, sponsored by Boehringer Mannheim Corp.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 1993-03-10.
- Submission: K930621
- Applicant / Sponsor: Boehringer Mannheim Corp.
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5270
- Decision date: 1993-03-10
Classification & Regulation
This clearance is catalogued under FDA product code DCK and 21 CFR 866.5270, within the Immunology review panel as a Class II device.